{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05322577",
            "orgStudyIdInfo": {
                "id": "20210099"
            },
            "organization": {
                "fullName": "Amgen",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer.",
            "officialTitle": "A Phase 1b/2 Study Evaluating the Safety, Tolerability, Efficacy, and Pharmacokinetics of Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer (FORTITUDE-103).",
            "acronym": "FORTITUDE-103",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-study-evaluating-bemarituzumab-in-combination-with-other-anti-cancer-therapies-in-subjects-with-previously-untreated-advanced-gastric-or-gastroesophageal-junction-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-05-17",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-03-17",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-04-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-04-04",
            "studyFirstSubmitQcDate": "2022-04-04",
            "studyFirstPostDateStruct": {
                "date": "2022-04-12",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-10",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-12",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Amgen",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The main objectives of this study are to evaluate the safety and tolerability of bemarituzumab in combination with other anti-cancer therapies, and to evaluate the efficacy of bemarituzumab in combination with S-1 and oxaliplatin (SOX) and nivolumab as assessed by objective response."
        },
        "conditionsModule": {
            "conditions": [
                "Gastric Cancer",
                "Gastroesophageal Junction Cancer"
            ],
            "keywords": [
                "Gastric Cancer",
                "Gastroesophageal Junction Cancer",
                "Bemarituzumab",
                "FGFR2b Overexpression"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "BASIC_SCIENCE",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 80,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Part 1 Cohort A: Bemarituzumab with CAPOX",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Bemarituzumab",
                        "Drug: CAPOX"
                    ]
                },
                {
                    "label": "Part 1 Cohort C: Bemarituzumab with CAPOX and Nivolumab",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Bemarituzumab",
                        "Drug: CAPOX",
                        "Drug: Nivolumab"
                    ]
                },
                {
                    "label": "Part 1 Cohort D: Bemarituzumab with SOX and Nivolumab",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Bemarituzumab",
                        "Drug: SOX",
                        "Drug: Nivolumab"
                    ]
                },
                {
                    "label": "Part 2: Bemarituzumab with SOX and Nivolumab.",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Bemarituzumab",
                        "Drug: SOX",
                        "Drug: Nivolumab"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Bemarituzumab",
                    "description": "Intravenous (IV) infusion",
                    "armGroupLabels": [
                        "Part 1 Cohort A: Bemarituzumab with CAPOX",
                        "Part 1 Cohort C: Bemarituzumab with CAPOX and Nivolumab",
                        "Part 1 Cohort D: Bemarituzumab with SOX and Nivolumab",
                        "Part 2: Bemarituzumab with SOX and Nivolumab."
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "CAPOX",
                    "description": "CAPOX administered as a combination of oxaliplatin as an IV infusion and capecitabine orally as tablets.",
                    "armGroupLabels": [
                        "Part 1 Cohort A: Bemarituzumab with CAPOX",
                        "Part 1 Cohort C: Bemarituzumab with CAPOX and Nivolumab"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "SOX",
                    "description": "SOX administered as a combination of oxaliplatin as an IV infusion and S-1 orally.",
                    "armGroupLabels": [
                        "Part 1 Cohort D: Bemarituzumab with SOX and Nivolumab",
                        "Part 2: Bemarituzumab with SOX and Nivolumab."
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Nivolumab",
                    "description": "IV infusion.",
                    "armGroupLabels": [
                        "Part 1 Cohort C: Bemarituzumab with CAPOX and Nivolumab",
                        "Part 1 Cohort D: Bemarituzumab with SOX and Nivolumab",
                        "Part 2: Bemarituzumab with SOX and Nivolumab."
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Part 1: Number of Participants Who Experience a Dose-limiting Toxicity (DLT)",
                    "timeFrame": "Day 1 up to Day 21"
                },
                {
                    "measure": "Part 1: Number of Participants Who Experience a Treatment-emergent Adverse Event (TEAE)",
                    "timeFrame": "Day 1 to end of treatment (up to approximately 1 year)"
                },
                {
                    "measure": "Part 2: Objective Response (OR) as per Response Evaluation Criteria in Solid Tumors (RECIST v1.1)",
                    "timeFrame": "Up to 30 Months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Part 1: Area Under the Concentration-time Curve (AUC) of Bemarituzumab",
                    "timeFrame": "Day 1 to end of treatment (up to approximately 1 year)"
                },
                {
                    "measure": "Part 1: Maximum Observed Concentration (Cmax) of Bemarituzumab",
                    "timeFrame": "Day 1 to end of treatment (up to approximately 1 year))"
                },
                {
                    "measure": "Part 1: Observed Concentration at the end of a Dose Interval (Ctrough) of Bemarituzumab",
                    "timeFrame": "Day 1 to end of treatment (up to approximately 1 year)"
                },
                {
                    "measure": "Part 1: OR per RECIST v1.1",
                    "timeFrame": "Up to 2 years"
                },
                {
                    "measure": "Part 1: Duration of Response (DoR) per RECIST v1.1",
                    "timeFrame": "Up to 2 years"
                },
                {
                    "measure": "Part 1: Disease Control Rate (DCR)",
                    "timeFrame": "Up to 2 years"
                },
                {
                    "measure": "Part 1: Progression-free Survival (PFS) per RECIST v1.1",
                    "timeFrame": "Up to 2 years"
                },
                {
                    "measure": "Part 1: Overall Survival (OS)",
                    "timeFrame": "Up to 2 years"
                },
                {
                    "measure": "Part 2: Number of Participants Who Experience TEAEs",
                    "timeFrame": "Up to 30 months"
                },
                {
                    "measure": "Part 2: DoR per RECIST v1.1",
                    "timeFrame": "Up to 30 months"
                },
                {
                    "measure": "Part 2: Time to Response (TTR) per RECIST v1.1",
                    "timeFrame": "Up to 30 months"
                },
                {
                    "measure": "Part 2: Disease Control (DC) per RECIST v1.1",
                    "timeFrame": "Up to 30 months"
                },
                {
                    "measure": "Part 2: PFS per RECIST v1.1",
                    "timeFrame": "Up to 30 months"
                },
                {
                    "measure": "Part 2: OS",
                    "timeFrame": "Up to 30 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Adults with unresectable, locally advanced or metastatic gastric or gastroesophageal junction cancer not amendable to curative therapy.\n* Ability to provide tumor sample, either archival (obtained within 6 months to joining study) or fresh biopsy.\n* For certain arms for Part 1, FGFR2b overexpression positive defined as any FGFR2b 2+/3+ TC determined by centrally performed immunohistochemistry (IHC), based on tumor sample provided.\n* For Part 2, FGFR2b overexpression positive defined as FGFR2b \u226510% 2+/3+ TC determined by centrally performed IHC testing, based on tumor sample provided.\n* Easter Cooperative Oncology Group (ECOG) performance score less than or equal to 1.\n* Measurable or non-measurable disease as long as evaluable by Response Evaluation Criteria Solid Tumors (RECIST) version 1.1\n* Participant has no contradictions to CAPOX/SOX plus or minus nivolumab.\n* Adequate organ function.\n* For Part 2, measurable disease according to RECIST v1.1.\n\nExclusion Criteria:\n\n* Prior treatment for metastatic or unresectable disease (Note: prior adjuvant or neo-adjuvant therapy for local disease is allowed if ended more than 6 months of 1st dose).\n* Prior treatment with any selective inhibitor of fibroblast growth factor - fibroblast growth factor receptor (FGF-FGFR) pathway.\n* Known human epidermal growth factor receptor 2 (HER2) positive\n* Untreated or symptomatic central nervous system (CNS) disease or brain metastases.\n* Peripheral sensory neuropathy greater than or equal to Grade 2.\n* Clinically significant cardiac disease.\n* Other malignancy within the last 2 years (exceptions for definitively treated disease).\n* Chronic or systemic ophthalmological disorders.\n* Major surgery or other investigational study within 28 days of first study treatment dose.\n* Palliative radiotherapy within 14 days of first study treatment dose.\n* Abnormalities of the cornea that may pose an increased risk of developing a corneal ulcer.\n* History or evidence of systemic disease or ophthalmological disorders requiring chronic use of ophthalmic corticosteroids.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "100 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Amgen Call Center",
                    "role": "CONTACT",
                    "phone": "866-572-6436",
                    "email": "medinfo@amgen.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "MD",
                    "affiliation": "Amgen",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Northport Veterans Affairs Medical Center",
                    "status": "TERMINATED",
                    "city": "Northport",
                    "state": "New York",
                    "zip": "11768",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.90093,
                        "lon": -73.34317
                    }
                },
                {
                    "facility": "Hirosaki University Hospital",
                    "status": "RECRUITING",
                    "city": "Hirosaki-shi",
                    "state": "Aomori",
                    "zip": "036-8563",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 40.59306,
                        "lon": 140.4725
                    }
                },
                {
                    "facility": "Fukui Prefectural Hospital",
                    "status": "RECRUITING",
                    "city": "Fukui-Shi",
                    "state": "Fukui",
                    "zip": "910-8526",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 36.06443,
                        "lon": 136.22257
                    }
                },
                {
                    "facility": "Kyushu University Hospital",
                    "status": "RECRUITING",
                    "city": "Fukuoka-shi",
                    "state": "Fukuoka",
                    "zip": "812-8582",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 33.6,
                        "lon": 130.41667
                    }
                },
                {
                    "facility": "Fukushima Medical University Hospital",
                    "status": "RECRUITING",
                    "city": "Fukushima-shi",
                    "state": "Fukushima",
                    "zip": "960-1295",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 37.75,
                        "lon": 140.46667
                    }
                },
                {
                    "facility": "Ogaki Municipal Hospital",
                    "status": "TERMINATED",
                    "city": "Ogaki-shi",
                    "state": "Gifu",
                    "zip": "503-8502",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.35,
                        "lon": 136.61667
                    }
                },
                {
                    "facility": "Gunma University Hospital",
                    "status": "RECRUITING",
                    "city": "Maebashi-shi",
                    "state": "Gunma",
                    "zip": "371-8511",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 36.4,
                        "lon": 139.08333
                    }
                },
                {
                    "facility": "Hiroshima University Hospital",
                    "status": "RECRUITING",
                    "city": "Hiroshima-shi",
                    "state": "Hiroshima",
                    "zip": "734-8551",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 34.4,
                        "lon": 132.45
                    }
                },
                {
                    "facility": "Ibaraki Prefectural Central Hospital",
                    "status": "RECRUITING",
                    "city": "Kasama-shi",
                    "state": "Ibaraki",
                    "zip": "309-1793",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 36.38333,
                        "lon": 140.26667
                    }
                },
                {
                    "facility": "St Marianna University Hospital",
                    "status": "RECRUITING",
                    "city": "Kawasaki-shi",
                    "state": "Kanagawa",
                    "zip": "216-8511",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.52056,
                        "lon": 139.71722
                    }
                },
                {
                    "facility": "Kanagawa Prefectural Hospital Organization Kanagawa Cancer Center",
                    "status": "RECRUITING",
                    "city": "Yokohama-shi",
                    "state": "Kanagawa",
                    "zip": "241-8515",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.43333,
                        "lon": 139.65
                    }
                },
                {
                    "facility": "Kochi Health Sciences Center",
                    "status": "RECRUITING",
                    "city": "Kochi-shi",
                    "state": "Kochi",
                    "zip": "781-8555",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 33.55,
                        "lon": 133.53333
                    }
                },
                {
                    "facility": "Tohoku University Hospital",
                    "status": "RECRUITING",
                    "city": "Sendai-shi",
                    "state": "Miyagi",
                    "zip": "980-8574",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 38.26667,
                        "lon": 140.86667
                    }
                },
                {
                    "facility": "Okayama University Hospital",
                    "status": "RECRUITING",
                    "city": "Okayama-shi",
                    "state": "Okayama",
                    "zip": "700-8558",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 34.65,
                        "lon": 133.93333
                    }
                },
                {
                    "facility": "Osaka General Medical Center",
                    "status": "RECRUITING",
                    "city": "Osaka-shi",
                    "state": "Osaka",
                    "zip": "558-8558",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 34.69374,
                        "lon": 135.50218
                    }
                },
                {
                    "facility": "Osaka Medical and Pharmaceutical University Hospital",
                    "status": "RECRUITING",
                    "city": "Takatsuki-shi",
                    "state": "Osaka",
                    "zip": "569-8686",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 34.84833,
                        "lon": 135.61678
                    }
                },
                {
                    "facility": "Shizuoka General Hospital",
                    "status": "RECRUITING",
                    "city": "Shizuoka-shi",
                    "state": "Shizuoka",
                    "zip": "420-8527",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 34.98333,
                        "lon": 138.38333
                    }
                },
                {
                    "facility": "Shizuoka Cancer Center",
                    "status": "RECRUITING",
                    "city": "Sunto-gun",
                    "state": "Shizuoka",
                    "zip": "411-8777",
                    "country": "Japan"
                },
                {
                    "facility": "Dokkyo Medical University Hospital",
                    "status": "RECRUITING",
                    "city": "Shimotsuga-gun",
                    "state": "Tochigi",
                    "zip": "321-0293",
                    "country": "Japan"
                },
                {
                    "facility": "National Cancer Center Hospital",
                    "status": "RECRUITING",
                    "city": "Chuo-ku",
                    "state": "Tokyo",
                    "zip": "104-0045",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.57779,
                        "lon": 139.71685
                    }
                },
                {
                    "facility": "IMSUT Hospital, The Institute of Medical Science The University of Tokyo",
                    "status": "RECRUITING",
                    "city": "Minato-ku",
                    "state": "Tokyo",
                    "zip": "108-8639",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 34.2152,
                        "lon": 135.1501
                    }
                },
                {
                    "facility": "Toyama University Hospital",
                    "status": "RECRUITING",
                    "city": "Toyama-shi",
                    "state": "Toyama",
                    "zip": "930-0194",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 36.7,
                        "lon": 137.21667
                    }
                },
                {
                    "facility": "Seoul National University Bundang Hospital",
                    "status": "RECRUITING",
                    "city": "Seongnam-si, Gyeonggi-do",
                    "zip": "13620",
                    "country": "Korea, Republic of"
                },
                {
                    "facility": "Seoul National University Hospital",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "03080",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Severance Hospital Yonsei University Health System",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "03722",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Asan Medical Center",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "05505",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Samsung Medical Center",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "06351",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "National University Hospital",
                    "status": "RECRUITING",
                    "city": "Singapore",
                    "zip": "119074",
                    "country": "Singapore",
                    "geoPoint": {
                        "lat": 1.28967,
                        "lon": 103.85007
                    }
                },
                {
                    "facility": "National Taiwan University Hospital",
                    "status": "RECRUITING",
                    "city": "Taipei",
                    "zip": "10002",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 25.04776,
                        "lon": 121.53185
                    }
                },
                {
                    "facility": "Taipei Veterans General Hospital",
                    "status": "RECRUITING",
                    "city": "Taipei",
                    "zip": "11217",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 25.04776,
                        "lon": 121.53185
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "AmgenTrials clinical trials website",
                    "url": "http://www.amgentrials.com"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "De-identified individual patient data for variables necessary to address the specific research question in an approved data sharing request.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "ICF",
                "CSR"
            ],
            "timeFrame": "Data sharing requests relating to this study will be considered beginning 18 months after the study has ended and either 1) the product and indication have been granted marketing authorization in both the US and Europe or 2) clinical development for the product and/or indication discontinues and the data will not be submitted to regulatory authorities. There is no end date for eligibility to submit a data sharing request for this study.",
            "accessCriteria": "Qualified researchers may submit a request containing the research objectives, the Amgen product(s) and Amgen study/studies in scope, endpoints/outcomes of interest, statistical analysis plan, data requirements, publication plan, and qualifications of the researcher(s). In general, Amgen does not grant external requests for individual patient data for the purpose of re-evaluating safety and efficacy issues already addressed in the product labelling. Requests are reviewed by a committee of internal advisors. If not approved, a Data Sharing Independent Review Panel will arbitrate and make the final decision. Upon approval, information necessary to address the research question will be provided under the terms of a data sharing agreement. This may include anonymized individual patient data and/or available supporting documents, containing fragments of analysis code where provided in analysis specifications. Further details are available at the URL below.",
            "url": "https://www.amgen.com/datasharing"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000013274",
                    "term": "Stomach Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000005770",
                    "term": "Gastrointestinal Neoplasms"
                },
                {
                    "id": "D000004067",
                    "term": "Digestive System Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000005767",
                    "term": "Gastrointestinal Diseases"
                },
                {
                    "id": "D000013272",
                    "term": "Stomach Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16064",
                    "name": "Stomach Neoplasms",
                    "asFound": "Gastric Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7256",
                    "name": "Digestive System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8886",
                    "name": "Gastrointestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M16062",
                    "name": "Stomach Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T5486",
                    "name": "Stomach Cancer",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000077594",
                    "term": "Nivolumab"
                },
                {
                    "id": "C000714767",
                    "term": "Bemarituzumab"
                }
            ],
            "ancestors": [
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000082082",
                    "term": "Immune Checkpoint Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M377",
                    "name": "Capecitabine",
                    "relevance": "LOW"
                },
                {
                    "id": "M1674",
                    "name": "Oxaliplatin",
                    "relevance": "LOW"
                },
                {
                    "id": "M1854",
                    "name": "Nivolumab",
                    "asFound": "Technique",
                    "relevance": "HIGH"
                },
                {
                    "id": "M342257",
                    "name": "Bemarituzumab",
                    "asFound": "Commit",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M2342",
                    "name": "Immune Checkpoint Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}